Researchers at the Terasaki Institute developed a novel microfluidic biosensing platform to monitor monoclonal antibody secretion in real time. The system integrates a photonic crystal biosensor with ...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced the launch of its TrailBlazer ™ Tag and TrailBlazer StarBright ™ Dye Label Kits.
Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious diseases like ...
BURLINGTON, Mass., April 15, 2022 /CSRwire/ – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced ...
KEYLYNK-013: A phase 3 study of pembrolizumab in combination with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy in ...
On Tuesday, the FDA approved Eli Lilly and Co’s (NYSE:LLY) Kisunla (donanemab) once-monthly injection for IV infusion) for adults with early symptomatic Alzheimer’s disease. Once-monthly, Kisunla is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results